Main Article Content

Oleksandr Nazarchuk
Dmytro Dmyrtriiev
Yuliana Babina
Mariia Faustova
Vita Burkot


Acinetobacter baumannii, local anesthetics, antiseptics, biofilms.


Background. About 60% of all nosocomial infections are caused by microorganisms found in biofilms. Acinetobacter baumannii, as a pathogen of nosocomial infections, occur more frequently in surgical hospitals.
The aim of the study was to study the in vitro formation of A. baumannii monotype biofilms under the influence of local anesthetics and antiseptics
Materials and methods. The antimicrobial activity of local anesthetics (0.25-0.5%, bupivacaine, 2.0% lidocaine, 0.75% ropivacaine) and antiseptics (decamethoxine 0.1%, octenidine 0.1%, chlorhexidine 0.05%) ) against clinical strains of A. baumannii and studied their ability to produce biofilms.
Results. The bacteriostatic effect of local anesthetics on A. baumannii within the current concentrations of these drugs, which provide analgesic effect, has been proven. The given results indicate that A.baumanni cultures have a pronounced ability to form biofilms. Clinical strains of opportunistic microorganisms A. baumannii circulating in the hospital environment are highly sensitive to antiseptics decamethoxine and octenidine, chlorhexidine has a weak bactericidal effect against acinetobacteria. The results of studying the effect of local anesthetics on the process of formation of the strain "young" biofilms showed the presence of a dose-dependent effect. The greatest inhibitory activity against "young" biofilms was detected under the combined action of the antiseptic decamethoxine (in concentrations, not exceeding 3.9 μg / ml) and anesthetics (OD-0,199-0,223) (p <0,05).
Conclusions. Scientific research on various aspects of the formation (or destruction) of bacterial biofilms is a relevant and promising area that will change approaches to the prophylaxis and treatment of a number of infections, including postoperative infectious complications.


Download data is not yet available.
Abstract 6 |


1. World Health Organization. Improving infection prevention and control at the health facility: interim practical manual supporting implementation of the WHO Guidelines on Core Components of Infection Prevention and Control Programmes. No. WHO/HIS/SDS/2018.10. World Health Organization, 2018.
2. Bogomolova NS., Bol´shakov LV., Kuznecova SM. Problema lecheniya gnoino-vospalitel´nykh oslozhneniy, obuslovlennykh Acinetobacter. Anesteziologiya i reanimatologiya. 2014; 1: 26-32. [In Russian]

3. Gusarov VG., Nesterova EE., Lashenkova NN. . Izmenenie antibiotikorezistentnosti nozokomial´noy mikroflory: rezul´taty vnedreniya strategii kontrolya antimikrobnoy terapii v mnogoprofil´nom stacionare. Epidemiologiya i infekcionnye bolezni. 2015; Т. 20. № 5:11-18 . [In Russian]
4. Salmanov AH. Antymikrobna rezystentnistʹ ta infektsiyi, asotsiyovani z medychnoyu dopomohoyu v Ukrayini. Epidemiolohichnyy zvit mulʹtytsentrovoho doslidzhennya (2010— 2014 rr.). Ahrar Media Hrup, 2015; 452 s [ In Ukrainian]
5. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015. Available from: portal/files/media/en/publications/Publications/antimicrobial-resistance-europe-2015.pdf
6. Boucher HW., Talbot GH., Bradley JS. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 2009; 48 (1): 1—12.
7. Salmanov AG. Resistance to antibiotics and biocides. International Journal of Antibiotics and Probiotics. 2017 Dec; 1 (2): 92-125. doi: 1-2.17.07. [in Ukrainian]
8. Jurenaite M., Markuckas A., Suziedeliene E. Identification and characterization of type II toxin-antitoxin systems in the opportunistic pathogen Acinetobacter baumannii. J. Bacteriol. 2013; 195 (14): 3165–3172.
9. Pedersen RM, Grønnemose RB, Stærk K, Asferg CA, Andersen TB, Kolmos HJ, et al. A method for quantification of epithelium colonization capacity by pathogenic bacteria. Frontiers in cellular and infection microbiology. 2018; 8:16.
10. Babina YuM., Nazaruk OA., Dmytriiev DV., et al. Doslidzhennya chutlyvosti klinichnykh shtamiv S. aureus do antyseptyka dekametoksynu ta mistsevykh anestetykiv. Art of Medicine. 2020; 3(15): 17-22. [in Ukrainian]
11. Mahmoud MF., Fathy FM., Gohar MK., & Soliman, MH. Biofilm Formation And Quorum Sensing lasRGene Of Pseudomonas Aeruginosa Isolated From Patients With Post-Operative Wound Infections. European Journal of Molecular & Clinical Medicine. 2021; 8(2), 2177-2189.
12. Gabrielyan NI., et al. Gospital'naya mikroflora i bioplenki. Vestnik transplantologii i iskusstvennykh organov, 2014, 14.3: 83-91. [In Russian]